via UCL
Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn’s Disease within a few years.
It is published in The Journal of Clinical Investigation today.
The discovery of the molecular pathway regulated by a tiny molecule – known as microRNA-142 – is a major advance in our understanding of the immune system.
The 10-year-study found that microRNA-142 controls Regulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, they found, the most highly expressed regulator in the immune system.
Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering. But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit
Professor Graham Lord
And according to Professor Lord, the discovery could be translated into a viable drug treatment within a few years.
He said: “Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering.
“But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit.”
If the activity of Regulatory T cells is too low, this can cause other immune cells to attack our own body tissues. If these Regulatory T cells are too active, this leads to suppression of immune responses and can allow cancers to evade the immune system.
So being able to control them is a major step forward in our ability to control- and harness – the therapeutic power of the immune system.
Professor Richard Jenner from UCL, who led the computational side of the project, said that: “We were able to trace the molecular fingerprints of this molecule across other genes to determine how it acted as such a critical regulator.”
Professor Lord, now Vice President and Dean of the Faculty of Biology, Medicine and Health at The University of Manchester, added: “Scientists over the past decade or so have developed therapies which are able to modulate different pathways of the immune system. We hope that this new discovery will lead to the development of new ways to treat autoimmunity, infectious diseases and cancer and we are incredibly excited about where this may lead.”
The Latest on: Autoimmune diseases
via Google News
The Latest on: Autoimmune diseases
- Humans and autoimmune diseases continue to evolve togetheron November 28, 2019 at 9:09 am
The ability to fight disease is a driving force in human survival. Inflammation has emerged as a key weapon in this process. As pathogens change and evolve, the immune system adapts to keep up. Share ...
- Roles of aminoacyl-tRNA synthetases in immune regulation and immune diseaseson November 28, 2019 at 5:25 am
Meanwhile, we describe the functional mechanisms of ARSs in the development of immune cells. In addition, we focus on the roles of ARSs in certain immune diseases, such as autoimmune diseases, ...
- Worldwide Autoimmune Disease Diagnostics Market Analysis and Outlook, 2018-2019 and 2025 - ResearchAndMarkets.comon November 27, 2019 at 4:12 pm
The "Autoimmune Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025" report has been added to ResearchAndMarkets.com's offering. This report includes the latest predictions ...
- Humans co-evolved with immune-related diseases -- and it's still happeningon November 27, 2019 at 1:37 pm
Some of the same mutations allowing humans to fend off deadly infections also make us more prone to certain inflammatory and autoimmune diseases, such as Crohn's disease. Researchers describe how ...
- Autoimmune Disease Drug Market Is Projected to Grow at a CAGR of 4.3 % During the Forecast Periodon November 27, 2019 at 9:00 am
Pune, India -- (SBWIRE) -- 11/27/2019 -- Infinium Global Research has added a new report on "Autoimmune Disease Drug Market (Indication - Diabetes Mellitus Type 1, Rheumatic Diseases, Multiple ...
- New method enables easier and faster detection of celiac disease antibodieson November 27, 2019 at 6:04 am
This technology could revolutionize the serodiagnosis of microbial, autoimmune and allergic disorders. Now this team of researchers have applied the new concept for diagnostics of celiac disease. Most ...
- The Trick of Treating Cancer in Autoimmune Diseaseson November 25, 2019 at 6:15 pm
"But for patients with autoimmune disease, it comes with a catch." Immunotherapy helps a patient's immune system locate and destroy tumor cells, he explained here at the American College of ...
- Autoimmune Disease Diagnostics Market Comprehensive Analysis, Share, Growth Forecast from 2018 to 2024on November 21, 2019 at 9:19 pm
Nov 22, 2019 (AmericaNewsHour) -- Market Study Report LLC has recently added a report on Autoimmune Disease Diagnostics Market which provides a succinct analysis of the market size, revenue forecast, ...
- Global Autoimmune Partnering Deal Trends, Players and Financials Directory 2019on November 21, 2019 at 3:41 pm
Global Autoimmune Partnering 2014 to 2019 provides the full collection of Autoimmune disease deals signed between the world's pharmaceutical and biotechnology companies since 2014. Most of the deals ...
- Could sphingolipids help solve a racial paradox in heart disease?on November 20, 2019 at 1:32 pm
Complicating this narrative, however, is the higher risk of severe heart disease in African Americans, despite the fact that they tend to have higher levels of HDL and lower levels of triglycerides.
via Bing News
